Hsbc Holdings PLC Forte Biosciences, Inc. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.96 - $28.0 $1,114 - $32,508
-1,161 Reduced 9.75%
10,745 $10,000
Q3 2022

Nov 14, 2022
SELL
$1.06 - $27.75 $916 - $24,003
-865 Reduced 6.77%
11,906 $13,000
Q2 2022

Aug 11, 2022
BUY
$1.07 - $1.55 $17 - $24
16 Added 0.13%
12,771 $17,000
Q4 2021

Feb 11, 2022
BUY
$2.02 - $3.36 $25,765 - $42,856
12,755 New
12,755 $27,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $371M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email